15min chapter

The Rich Roll Podcast cover image

Does The Microbiome Hold The Key To Treating Parkinson’s, Autism & Other Diseases? CalTech Microbiologist Dr. Sarkis Mazmazian on The Gut-Brain Axis

The Rich Roll Podcast

CHAPTER

FDA's Perspective on Human-Derived Therapies and Microbiome Interventions

Exploring the FDA's view on human-derived therapies, focusing on the safety and education around using microbes from one person in another. The discussion compares the safety of human microbiome interventions to traditional new molecules in drug development and emphasizes drug effectiveness based on specificity and potency. The chapter delves into the potential impact of the microbiome on neurological disorders, highlighting challenges in applying microbiome-based therapeutics to complex diseases like Alzheimer's while showing promise for conditions like depression.

00:00

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode